Delcath Systems (DCTH)
11.19
0.00 (0.00%)
Upcoming Events
Latest Headlines
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
May 26, 2026 4:01 PM - BizWire
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2026 4:01 PM - BizWire
Form 4 DELCATH SYSTEMS, INC. For: May 13 Filed by: Sylvester John Richard
May 14, 2026 5:47 PM - SEC Filing
Form 4 DELCATH SYSTEMS, INC. For: May 13 Filed by: Martell Bridget A
May 14, 2026 5:46 PM - SEC Filing
Form 4 DELCATH SYSTEMS, INC. For: May 13 Filed by: CZEREPAK ELIZABETH
May 14, 2026 5:45 PM - SEC Filing
Form 4 DELCATH SYSTEMS, INC. For: May 13 Filed by: Aharon Gil
May 14, 2026 5:45 PM - SEC Filing
Form 4 DELCATH SYSTEMS, INC. For: May 13 Filed by: SALAMON STEVEN A J
May 14, 2026 5:45 PM - SEC Filing
Form 8-K DELCATH SYSTEMS, INC. For: May 13
May 14, 2026 8:24 AM - SEC Filing
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 12, 2026 8:00 AM - BizWire
Form 10-Q DELCATH SYSTEMS, INC. For: Mar 31
May 7, 2026 9:10 AM - SEC Filing
Form 8-K DELCATH SYSTEMS, INC. For: May 07
May 7, 2026 8:12 AM - SEC Filing
Delcath Systems (DCTH) Tops Q1 EPS by 7c
May 7, 2026 8:07 AM - StreetInsider
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
May 7, 2026 8:00 AM - BizWire
Delcath Systems presents liver cancer treatment data at breast cancer congress
May 7, 2026 7:01 AM - StreetInsider
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026
May 7, 2026 7:00 AM - BizWire
Form SCHEDULE 13G/A DELCATH SYSTEMS, INC. Filed by: BlackRock, Inc.
April 27, 2026 4:14 PM - SEC Filing
Delcath Systems to Host First Quarter 2026 Earnings Call
April 23, 2026 8:30 AM - BizWire
Delcath CHEMOSAT therapy included in European uveal melanoma guidelines
April 6, 2026 8:31 AM - StreetInsider
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines f
April 6, 2026 8:30 AM - BizWire
Form ARS DELCATH SYSTEMS, INC. For: Dec 31
April 2, 2026 8:56 AM - SEC Filing
Form DEFA14A DELCATH SYSTEMS, INC.
April 2, 2026 8:56 AM - SEC Filing
Form DEF 14A DELCATH SYSTEMS, INC. For: May 13
April 2, 2026 8:53 AM - SEC Filing
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting
April 1, 2026 8:30 AM - BizWire
Form SCHEDULE 13G DELCATH SYSTEMS, INC. Filed by: Kaufman Daniel Louis
March 20, 2026 1:25 PM - SEC Filing
Full Article List
